ILLUMINA INC (ILMN:NASDAQ)
$192.98 3.51 (1.8525%)
Analysed ILLUMINA INC (ILMN:NASDAQ) News Sources
3 Profitable Stocks We Find Risky
22-07-2026
yahoo.com
3 Healthcare Stocks with Questionable Fundamentals
23-07-2026
yahoo.com
AstraZeneca (LSE:AZN) And The Valuation Case Behind Its Drug Pipeline Narrative
24-07-2026
yahoo.com
Reading Between The Lines Of DHR's Latest Call
24-07-2026
trefis.com
Are Medical Stocks Lagging Celldex Therapeutics (CLDX) This Year?
24-07-2026
yahoo.com
EXEL vs. ILMN: Which Stock Is the Better Value Option?
24-07-2026
yahoo.com
What Are You Really Paying For Inside IJH?
24-07-2026
trefis.com
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
28-07-2026
yahoo.com
Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences
28-07-2026
yahoo.com
[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
28-07-2026
yahoo.com
What is the current price of ILLUMINA INC (ILMN:NASDAQ)?
The current price of ILLUMINA INC (ILMN:NASDAQ) is $192.98.
ILLUMINA INC (ILMN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ILLUMINA INC (ILMN:NASDAQ) since the previous trading day is $3.51.
ILLUMINA INC (ILMN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ILLUMINA INC (ILMN:NASDAQ) since the previous trading day is 1.8525%.
What is the most recent average sentiment score for ILLUMINA INC (ILMN:NASDAQ)?
The most recent average sentiment score for ILLUMINA INC (ILMN:NASDAQ) is 49 out of 100.
What is the most recent average sentiment for ILLUMINA INC (ILMN:NASDAQ)?
The most recent sentiment for ILLUMINA INC (ILMN:NASDAQ) is .
SEC-8K** Filing Available For ILLUMINA INC (ILMN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.